The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / U.S. Senate Votes to Confirm Azar as Health Secretary

U.S. Senate Votes to Confirm Azar as Health Secretary

January 24, 2018 • By Reuters Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF

WASHINGTON (Reuters)—The U.S. Senate on Wednesday voted to confirm former pharmaceutical industry executive and lobbyist Alex Azar as the next Health and Human Services secretary.

You Might Also Like
  • U.S. Senate Committee Advances Azar Nomination as Health Secretary
  • Trump to Tap Ex-Pharma Executive Azar as U.S. Health Secretary
  • Ex-Pharma Exec Azar Is Top Choice to Run U.S. Health Agency
Also By This Author
  • FDA Asks Endo to Withdraw Opana ER Opioid

Azar will oversee the Trump administration’s response to the opioid epidemic, its efforts to weaken the Affordable Care Act, commonly called Obamacare, and address rising prescription drug prices. The Senate voted 55-43 in favor of his nomination.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Most Democrats opposed Azar’s nomination, and several delivered impassioned speeches on Tuesday and Wednesday that criticized Azar for raising drug prices while he was at U.S. pharmaceutical firm Eli Lilly & Co, where he spent five years as president of its U.S. unit. Several patient and consumer advocacy groups opposed Azar’s nomination because of drug price increases at Lilly under his watch.

“Mr. Azar’s nomination is a perfect encapsulation of the president’s broken promises on prescription drugs and healthcare overall,” Democratic Senator Ron Wyden said on Tuesday in a Senate floor speech.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Republicans and some medical groups said Azar, who also served as general counsel and deputy secretary for Health and Human Services under former Republican President George W. Bush, had extensive qualifications for the job.

Trump’s first health secretary, former U.S. Representative Tom Price, resigned in September amid a furor over his use of expensive taxpayer-funded private charter jets for government travel.

 

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Filed Under: Uncategorized Tagged With: Alex Azar, Health and Human Services secretary

You Might Also Like:
  • U.S. Senate Committee Advances Azar Nomination as Health Secretary
  • Trump to Tap Ex-Pharma Executive Azar as U.S. Health Secretary
  • Ex-Pharma Exec Azar Is Top Choice to Run U.S. Health Agency
  • U.S. Senate Confirms Rep. Price as Health Secretary

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.